Insulet Corp (NASDAQ:PODD)
| 159.98 BATS BZX Real-Time Price As of 3:28pm ET |  -3.89 / -2.37%Today’s Change | 152.43 Today|||52-Week Range 335.91 | -45.66% Year-to-Date |
Latest PODD News | Press Releases
| Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year? 8:17am / MotleyFool.com - Paid Partner Content | Insulet (PODD)'s True Worth: A Comprehensive Analysis of Its Market Value Sep 26 / GuruFocus News - Paid Partner Content |
| DexCom (DXCM) Partners With RxFood for Automated Dietary Monitoring Sep 27 / Zacks.com - Paid Partner Content | Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick Sep 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 163.87 |
| Today’s open | 163.50 |
| Day’s range | 159.07 - 163.82 |
| Volume | 33,421 |
| Average volume (3 months) | 938,166 |
| Market cap | $10.9B |
Data as of 3:28pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -73.29% |
| Earnings growth (this year) | +2,045.26% |
| Earnings growth (next 5 years) | +37.00% |
| Revenue growth (last year) | +18.79% |
| P/E ratio | 177.8 |
| Price/Sales | 15.77 |
| Price/Book | 22.72 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PENPenumbra Inc | -4.78 | -1.94% |
| TFXTeleflex Inc | -1.61 | -0.81% |
| SWAVShockwave Medical In... | -5.53 | -2.69% |
| ---- |
Data as of 3:29pm ET, 09/29/2023
Financials
| Next reporting date | November 3, 2023 |
| EPS forecast (this quarter) | $0.39 |
| Annual revenue (last year) | $1.3B |
| Annual profit (last year) | $4.6M |
| Net profit margin | 0.35% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Acton, Massachusetts |
Forecasts
